IOVS Journal of Biological Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:877-883.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0777

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gherghel, D.
Right arrow Articles by Hosking, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gherghel, D.
Right arrow Articles by Hosking, S. L.

Systemic Reduction in Glutathione Levels Occurs in Patients with Primary Open-Angle Glaucoma

Doina Gherghel,1,2 Helen Rosemary Griffiths,1 Emma Jane Hilton,1,2 Ian Andrew Cunliffe,2 and Sarah Louise Hosking1,2

1From the School of Life and Health Sciences, Aston University, Birmingham, United Kingdom; and the 2Department of Ophthalmology, Heartlands and Solihull NHS Trust, Birmingham, United Kingdom.

PURPOSE. To assess the level of plasma glutathione in patients with untreated primary open-angle glaucoma.

METHODS. Twenty-one patients with newly diagnosed primary open-angle glaucoma and 34 age- and gender-matched control subjects were subjected to a blood analysis to detect the level of circulating glutathione in its reduced and oxidized forms. The effect of age, gender, and systemic blood pressure on circulating glutathione levels was also analyzed.

RESULTS. Age had a negative effect on the level of both reduced and total glutathione (P = 0.002, r = –0.52 and P = 0.002, r = –0.52, respectively) in control subjects but not in patients with glaucoma (P > 0.05, r = 0.27, and P > 0.05, r = 0.22, respectively). In the control group, men demonstrated higher levels of both reduced and total glutathione than did women (P = 0.024 and P = 0.032, respectively). After correction for age and gender influences on blood glutathione levels, patients with glaucoma exhibited significantly lower levels of reduced and total glutathione than did control subjects (P = 0.010, F = 7.24 and P = 0.006, F = 8.38, respectively). No differences between study groups were observed in either oxidized glutathione levels or redox index (P > 0.05, F = 0.50; and P > 0.05, F = 0.30, respectively).

CONCLUSIONS. Patients with glaucoma exhibit low levels of circulating glutathione, suggesting a general compromise of the antioxidative defense.





This article has been cited by other articles:


Home page
IOVSHome page
R. Fernandez-Durango, A. Fernandez-Martinez, J. Garcia-Feijoo, A. Castillo, J. M. de la Casa, B. Garcia-Bueno, B. G. Perez-Nievas, A. Fernandez-Cruz, and J. C. Leza
Expression of Nitrotyrosine and Oxidative Consequences in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2506 - 2511.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. He, K. W. Leung, Y.-H. Zhang, S. Duan, X.-F. Zhong, R.-Z. Jiang, Z. Peng, J. Tombran-Tink, and J. Ge
Mitochondrial Complex I Defect Induces ROS Release and Degeneration in Trabecular Meshwork Cells of POAG Patients: Protection by Antioxidants
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1447 - 1458.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Q. Liu, W.-K. Ju, J. G. Crowston, F. Xie, G. Perry, M. A. Smith, J. D. Lindsey, and R. N. Weinreb
Oxidative Stress Is an Early Event in Hydrostatic Pressure Induced Retinal Ganglion Cell Damage
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4580 - 4589.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Suemori, M. Shimazawa, K. Kawase, M. Satoh, H. Nagase, T. Yamamoto, and H. Hara
Metallothionein, an Endogenous Antioxidant, Protects against Retinal Neuron Damage in Mice.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3975 - 3982.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology